{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:09:53Z","timestamp":1788916193230,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jad.2020.10.023","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T12:25:10Z","timestamp":1602678310000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics"],"prefix":"10.1016","volume":"279","author":[{"given":"Ching-Hua","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Yu","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Chua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.10.023_bib0001","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR","year":"2000"},{"key":"10.1016\/j.jad.2020.10.023_bib0002","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jad.2020.10.023_bib0003","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2045125314540297","article-title":"The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal","volume":"4","author":"Brissos","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0004","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0005","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jad.2016.08.023","article-title":"Clinical outcomes of long-acting injectable risperidone in patients with bipolar I disorder: a 1-year retrospective cohort study","volume":"205","author":"Chan","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.15032su1","article-title":"The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence","volume":"77","author":"Correll","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0007","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamapsychiatry.2013.1394","article-title":"Comorbidities and mortality in bipolar disorder: a Swedish national cohort study","volume":"70","author":"Crump","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0008","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jphysparis.2013.03.006","article-title":"Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset","volume":"107","author":"Geoffroy","year":"2013","journal-title":"J. Physiol. Paris"},{"key":"10.1016\/j.jad.2020.10.023_bib0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/11631310-000000000-00000","article-title":"Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder","volume":"26","author":"Gigante","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2020.10.023_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13696998.2017.1379412","article-title":"Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder","volume":"21","author":"Greene","year":"2018","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.jad.2020.10.023_bib0011","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0012","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.euroneuro.2014.06.015","article-title":"Checking the plausibility of psychiatrists arguments for not prescribing depot medication","volume":"24","author":"Hamann","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0013","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/0004867415605171","article-title":"Predictors of psychiatric readmission among patients with bipolar disorder at an academic safety-net hospital","volume":"50","author":"Hamilton","year":"2016","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0014","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2146\/ajhp080374","article-title":"Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge","volume":"66","author":"Hassan","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.jad.2020.10.023_bib0015","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1176\/ps.2008.59.9.982","article-title":"Continuing care after inpatient psychiatric treatment for patients with psychiatric and substance use disorders","volume":"59","author":"Ilgen","year":"2008","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2020.10.023_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","article-title":"Medication nonadherence in bipolar disorder: a narrative review","volume":"8","author":"Jawad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0017","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40273-014-0250-y","article-title":"Cost-of-illness studies for bipolar disorder: systematic review of international studies","volume":"33","author":"Jin","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jad.2020.10.023_bib0018","author":"Kaplan","year":"2015"},{"key":"10.1016\/j.jad.2020.10.023_bib0019","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004714-199604001-00003","article-title":"Outcome in the pharmacologic treatment of bipolar disorder","volume":"16","author":"Keck","year":"1996","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0020","doi-asserted-by":"crossref","first-page":"g5673","DOI":"10.1136\/bmj.g5673","article-title":"Assessment and management of bipolar disorder: summary of updated NICE guidance","volume":"349","author":"Kendall","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2020.10.023_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40263-019-00629-z","article-title":"Long-acting injectable second-generation\/atypical antipsychotics for the management of bipolar disorder: a systematic review","volume":"33","author":"Keramatian","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2020.10.023_bib0022","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.bp.112.113548","article-title":"Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial","volume":"202","author":"Kessing","year":"2013","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1192\/bjp.185.5.372","article-title":"Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999","volume":"185","author":"Kessing","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyw038","article-title":"Long-acting injectable antipsychotics for prevention of relapse in bipolar disorder: a systematic review and meta-analyses of randomized controlled trials","volume":"19","author":"Kishi","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jamapsychiatry.2017.4711","article-title":"Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder","volume":"75","author":"Lahteenvuo","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/ijnp\/pyz035","article-title":"Time to rehospitalization in patients with schizophrenia receiving long-acting injectable antipsychotics or oral antipsychotics","volume":"22","author":"Lin","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0027","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2019.08.005","article-title":"A comparison of long-acting injectable antipsychotics with oral antipsychotics on time to rehospitalization within 1 year of discharge in elderly patients with schizophrenia","volume":"28","author":"Lin","year":"2020","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1590\/S1807-59322010000500005","article-title":"Predictors of psychiatric readmissions in the short- and long-term: a population-based study in Taiwan","volume":"65","author":"Lin","year":"2010","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jad.2020.10.023_bib0029","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40345-018-0131-y","article-title":"The challenges of living with bipolar disorder: a qualitative study of the implications for health care and research","volume":"6","author":"Maassen","year":"2018","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0031","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1177\/0004867412460593","article-title":"Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"46","author":"Magalhaes","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0032","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-5618.2011.00935.x","article-title":"Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables","volume":"13","author":"Mann-Wrobel","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0033","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1590\/S0080-62342012000300022","article-title":"[Bipolar affective disorder: pharmacotherapeutic profile and adherence to medication]","volume":"46","author":"Miasso","year":"2012","journal-title":"Rev. Esc. Enferm. USP"},{"key":"10.1016\/j.jad.2020.10.023_bib0034","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0035","series-title":"Therapeutics of Schizophrenia. Neuropsychopharmacology: The Fifth Generation of Progress","first-page":"775","author":"Miyamoto","year":"2002"},{"key":"10.1016\/j.jad.2020.10.023_bib0036","series-title":"Bipolar Disorder: The NICE Guideline on the Assessment and Management of Bipolar Disorder in Adults, Children and Young People in Primary and Secondary Care","year":"2018"},{"key":"10.1016\/j.jad.2020.10.023_bib0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-859X-12-32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review","volume":"12","author":"Olivares","year":"2013","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0038","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2019.02.003","article-title":"Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: a systematic review","volume":"29","author":"Pacchiarotti","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0039","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jphs.12004","article-title":"Association between adherence to and persistence with atypical antipsychotics and psychiatric relapse among US medicaid-enrolled patients with schizophrenia","volume":"4","author":"Panish","year":"2013","journal-title":"J. Pharm. Health Serv. Res."},{"key":"10.1016\/j.jad.2020.10.023_bib0040","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1176\/appi.ps.57.1.21","article-title":"Best practices: an initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital","volume":"57","author":"Patrick","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.jad.2020.10.023_bib0041","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","article-title":"Long-term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD)","volume":"55","author":"Perlis","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0042","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.clinthera.2017.08.008","article-title":"Treatment patterns, health care resource utilization, and spending in medicaid beneficiaries initiating second-generation long-acting injectable agents versus oral atypical antipsychotics","volume":"39","author":"Pilon","year":"2017","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jad.2020.10.023_bib0043","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.08m04994yel","article-title":"Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood","volume":"71","author":"Post","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0044","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-244X-13-261","article-title":"Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia","volume":"13","author":"Potkin","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0045","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bdi.12707","article-title":"Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis","volume":"20","author":"Prajapati","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0046","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0047","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.encep.2007.05.002","article-title":"[Predictors of prophylactic response to lithium]","volume":"34","author":"Rohayem","year":"2008","journal-title":"Encephale"},{"key":"10.1016\/j.jad.2020.10.023_bib0048","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.jcp.0000280310.50871.ff","article-title":"Treatment adherence in individuals with rapid cycling bipolar disorder: results from a clinical-trial setting","volume":"27","author":"Sajatovic","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2020.10.023_bib0049","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1399-5618.2006.00314.x","article-title":"Treatment adherence with antipsychotic medications in bipolar disorder","volume":"8","author":"Sajatovic","year":"2006","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0050","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bdi.12359","article-title":"Gray and white matter trajectories in patients with bipolar disorder","volume":"18","author":"Sani","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0051","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1176\/appi.ajp.159.11.1927","article-title":"Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization","volume":"159","author":"Scott","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.jad.2020.10.023_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4088\/JCP.7090su1cj","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0053","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2016.03.043","article-title":"Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder","volume":"197","author":"Wu","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0054","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/cer-2018-0068","article-title":"Impact of initiating long-acting injectable antipsychotics on hospitalization in patients with bipolar I disorder","volume":"7","author":"Yan","year":"2018","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.jad.2020.10.023_bib0055","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2020.10.023_bib0056","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2020.10.023_bib0057","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2011.06.016","article-title":"Annual cost of managing bipolar disorder to the UK healthcare system","volume":"133","author":"Young","year":"2011","journal-title":"J. Affect. Disord."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720328676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720328676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:52:09Z","timestamp":1759024329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720328676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":57,"alternative-id":["S0165032720328676"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.10.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time to rehospitalization in patients with bipolar mania discharged on long-acting injectable or oral antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}